References in periodicals archive ?
Describing how this new scientific paradigm can reshape our present sense of what Romanticism--and particularly Romantic poetry--is, Gigante draws upon an analogy proposed by Helmut Muller-Sievers, who suggested in 1997 that "the multifacted inquiry into the phenomena of life at this time placed the biological concepts of preformation and epigenesis 'in the same relation to each other as allegory and symbol,'" and that the struggle between them haunts us today (33).
Pangenesis was not, therefore, an alternative to epigenesis so much as a modification of it designed to show how the process described by Aristotle and his modern successors could slowly and gradually give rise to changing descriptions of lineages.
Although this agreement represents the 4th transaction of this type for Genta, EpiGenesis is the first such company to be actively engaged in ongoing clinical trials with an antisense product," said Mr.
EpiGenesis recently began clinical trials for its respirable antisense oligonucleotide (RASON), EPI-2010 for asthma, in the United States and UK.
EpiGenesis has pioneered a new form of antisense oligonucleotides known as Respirable Antisense Oligonucleotides (RASONs), designed for direct application to the lung via aerosol inhalation.
The epigenesis interpretation alone has no recent counterpart, since contemporary philosophers of mind favor bottom-up determination of mental states.
Ball was Director, Research-Clinical Interface at Epigenesis where he oversaw the asthma and COPD therapeutics programs.
CV Therapeutics - Aderis Pharmaceuticals (Discovery Therapeutics) - Epigenesis Pharmaceuticals - Genaissance Pharmaceuticals - Glaxo Group Ltd.
Before joining Chiron, he served as president and CEO of Epigenesis Pharmaceuticals, a privately held biopharmaceutical company developing inhaled respiratory medicines.
Dong-A, DOR BioPharma, Draxis Health, DuPont Pharmaceuticals, Eisai Co, Eisai Ltd, Elan, Eli Lilly and Company, Endocyte, EntreMed, Enzon, EpiGenesis, Epimmune, eXegenics, Exelixis, Eximias, Forest Laboratories UK Ltd, Fujisawa, Galderma, Gedeon Richter, Gemin X Biotechnologies, GemVax, Genaera, Genelabs, GeneMax Pharmaceuticals, Genentech Inc.
It recently announced a licensing transaction under which it will obtain rights to a 5-lipoxygenase inhibitor for asthma from Millennium Pharmaceuticals, and it has also entered into an agreement with EpiGenesis Inc.